Evidence map›Paper›PMID 30722022›Full record

ArticleThe Journal of infectious diseases2019

Effects of Sequential Influenza A(H1N1)pdm09 Vaccination on Antibody Waning.

Jon Zelner, Joshua G Petrie, Rob Trangucci, Emily T Martin, Arnold S Monto

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Influenza Vaccine Effectiveness: New Insights and Challenges.Cold Spring Harbor perspectives in medicine · 2021
    Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jon ZelnerDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor.
Joshua G PetrieDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor.
Rob TrangucciDepartment of Statistics, University of Michigan, Ann Arbor.
Emily T MartinDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor.
Arnold S MontoDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor.

Funding

Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness ResearchU01IP000474 · IP · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTO, ARNOLD S · 2011 to 2015
$6.2M
Household Studies of Influenza and Other Respiratory Viruses - Supplement: EV D68 SurveillanceR01AI097150 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTO, ARNOLD S, OHMIT, SUZANNE · 2012 to 2015
$2.0M
NCIRD CDC HHS U01 IP000474NCIRD CDC HHS U01 IP001034NIAID NIH HHS HHSN272201400006CNIAID NIH HHS R01 AI097150
6 · The paper itself

Abstract

backgroundAntibody waning following influenza vaccination has been repeatedly evaluated, but waning has rarely been studied in the context of longitudinal vaccination history.

methodsWe developed a Bayesian hierarchical model to assess the effects of sequential influenza A(H1N1)pdm09 vaccination on hemagglutination inhibition antibody boosting and waning in a longitudinal cohort of older children and adults from 2011 to 2016, a period during which the A(H1N1)pdm09 vaccine strain did not change.

resultsAntibody measurements from 2057 serum specimens longitudinally collected from 388 individuals were included. Average postvaccination antibody titers were similar across successive vaccinations, but the rate of antibody waning increased with each vaccination. The antibody half-life was estimated to decrease from 32 months (95% credible interval [CrI], 22-61 months) following first vaccination to 9 months (95% CrI, 7-15 months) following a seventh vaccination.

conclusionsAlthough the rate of antibody waning increased with successive vaccination, the estimated antibody half-life was longer than a typical influenza season even among the most highly vaccinated. This supports current recommendations for vaccination at the earliest opportunity. Patterns of boosting and waning might be different with the influenza A(H3N2) subtype, which evolves more rapidly and has been most associated with reduced effectiveness following repeat vaccination.

Indexed as

AdolescentAdultAntibodies, ViralBayes TheoremFemaleHemagglutination Inhibition TestsHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanInfluenza VaccinesMaleMiddle AgedProspective StudiesVaccinationYoung AdultAntibodies, ViralInfluenza Vaccinesantibodyhemagglutinininfluenzainfluenza vaccinewaning

Identifiers

PMID30722022
PMCPMC6548909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.